Tandem Diabetes Care (TNDM) News Today → Elon Musk’s PRIME is Set to Shock the World (From InvestorPlace) (Ad) Free TNDM Stock Alerts $47.30 +0.37 (+0.79%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 3:54 PM | marketbeat.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Position Lessened by Paradice Investment Management LLCParadice Investment Management LLC cut its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 28.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,081,886 shares of the medicalMay 17 at 4:55 AM | marketbeat.comNatixis Advisors L.P. Purchases Shares of 34,681 Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Natixis Advisors L.P. acquired a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,681 shares of the medicaMay 15 at 10:30 PM | msn.comEminence Capital's Q1 moves include adding MNDY, J, exiting SCHW, FROGMay 12, 2024 | msn.comFDA issues 'most serious type of recall' for insulin pump-related iOS appMay 11, 2024 | marketbeat.comM&T Bank Corp Purchases 26,943 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)M&T Bank Corp raised its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 118.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,649 shares of the medical device company's stock after acMay 9, 2024 | marketbeat.comTruist Financial Corp Takes $2.59 Million Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Truist Financial Corp acquired a new stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 87,484 shares of the medical device company's stock, valued at approximately $2,588,000. Truist FinanciMay 8, 2024 | marketbeat.comRussell Investments Group Ltd. Purchases 109,505 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Russell Investments Group Ltd. increased its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 79.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 247,325 shares of the medical deviceMay 8, 2024 | americanbankingnews.comTandem Diabetes Care (NASDAQ:TNDM) PT Raised to $55.00May 7, 2024 | msn.comTandem Diabetes Care GAAP EPS of -$0.65 beats by $0.12, revenue of $191.67M beats by $18.13MMay 6, 2024 | marketbeat.comLisanti Capital Growth LLC Invests $3.13 Million in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Lisanti Capital Growth LLC purchased a new position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 105,895 shares oMay 6, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $55.00 by Analysts at BarclaysBarclays lifted their target price on shares of Tandem Diabetes Care from $39.00 to $55.00 and gave the company an "overweight" rating in a research note on Monday.May 6, 2024 | markets.businessinsider.comBarclays Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)May 5, 2024 | finance.yahoo.comEarnings Update: Here's Why Analysts Just Lifted Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$43.57May 3, 2024 | fool.comWhy Tandem Diabetes Stock Just Jumped 22%May 3, 2024 | finance.yahoo.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call TranscriptMay 3, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month High After Analyst UpgradeTandem Diabetes Care (NASDAQ:TNDM) Hits New 12-Month High Following Analyst UpgradeMay 3, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Earns "Overweight" Rating from Piper SandlerPiper Sandler reiterated an "overweight" rating and set a $50.00 price target (up previously from $35.00) on shares of Tandem Diabetes Care in a report on Friday.May 3, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) PT Raised to $36.00Robert W. Baird increased their price objective on shares of Tandem Diabetes Care from $28.00 to $36.00 and gave the stock a "neutral" rating in a report on Friday.May 3, 2024 | marketwatch.comTandem Diabetes Care Shares Rise 17% on Raised 2024 Sales OutlookMay 3, 2024 | finance.yahoo.comTandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...May 3, 2024 | finance.yahoo.comQ1 2024 Tandem Diabetes Care Inc Earnings CallMay 2, 2024 | investorplace.comTNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | businesswire.comTandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial GuidanceMay 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY)April 30, 2024 | msn.comWells Fargo Upgrades Tandem Diabetes Care (TNDM)April 29, 2024 | finance.yahoo.comAre Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?April 29, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24April 29, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Upgraded to Overweight at Wells Fargo & CompanyWells Fargo & Company raised shares of Tandem Diabetes Care from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $21.00 to $45.00 in a report on Monday.April 26, 2024 | msn.comLeerink Partners Upgrades Tandem Diabetes Care (TNDM)April 26, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Lifted to Outperform at Leerink PartnrsLeerink Partnrs raised shares of Tandem Diabetes Care from a "market perform" rating to an "outperform" rating in a research note on Thursday.April 25, 2024 | marketbeat.comJennison Associates LLC Has $38.18 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Jennison Associates LLC grew its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 14.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,290,590 shares of the medical device company's stock after acquiring an additional 167,675 shares duApril 25, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Upgraded to "Outperform" by SVB LeerinkSVB Leerink upgraded Tandem Diabetes Care from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $34.00 to $45.00 in a research report on Thursday.April 23, 2024 | morningstar.comTandem Diabetes Care IncApril 23, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel NicolausStifel Nicolaus increased their price target on shares of Tandem Diabetes Care from $37.00 to $40.00 and gave the company a "buy" rating in a research report on Tuesday.April 23, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%Tandem Diabetes Care (NASDAQ:TNDM) Trading 7.9% HigherApril 17, 2024 | marketbeat.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.Mirae Asset Global Investments Co. Ltd. trimmed its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 15.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 130,858 shares of theApril 15, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%April 15, 2024 | marketbeat.comRaymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Raymond James & Associates grew its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 128.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,985 shares of the medical device company'sApril 14, 2024 | nasdaq.comValidea Detailed Fundamental Analysis - TNDMApril 11, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to SellStockNews.com lowered Tandem Diabetes Care from a "hold" rating to a "sell" rating in a research note on Thursday.April 9, 2024 | businesswire.comTandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024April 9, 2024 | gurufocus.comWhat's Driving Tandem Diabetes Care Inc's Surprising 25% Stock Rally?April 9, 2024 | finance.yahoo.comBullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of StockApril 7, 2024 | fool.com1 Beaten-Down Stock That Could Make You RicherApril 5, 2024 | finance.yahoo.comShould You Invest in Tandem Diabetes Care (TNDM)?April 3, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00Citigroup lifted their price target on Tandem Diabetes Care from $31.00 to $38.00 and gave the stock a "neutral" rating in a research report on Wednesday.April 2, 2024 | marketbeat.comChicago Capital LLC Has $14.11 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Chicago Capital LLC reduced its stake in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 47.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 476,937 shares of the medical device company's stock afteApril 1, 2024 | marketbeat.comTandem Diabetes Care (NASDAQ:TNDM) Shares Down 6.1% Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.1%April 1, 2024 | marketbeat.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Rating of "Hold" from BrokeragesTandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) has been given a consensus rating of "Hold" by the twelve analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation anMarch 30, 2024 | marketbeat.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Short Interest UpdateTandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 8,080,000 shares, an increase of 64.9% from the February 29th total of 4,900,000 shares. Based on an average daily trading volume, of 1,800,000 shares, the days-to-cover ratio is currently 4.5 days. Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s PRIME is Set to Shock the World (Ad)Must-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing. Click here for the full story… TNDM Media Mentions By Week TNDM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNDM News Sentiment▼1.130.50▲Average Medical News Sentiment TNDM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNDM Articles This Week▼45▲TNDM Articles Average Week Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NARI News IRTC News ICUI News PRCT News AXNX News NVCR News IART News LMAT News ATEC News MDXG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNDM) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceI’m afraid WWIII is a very real possibility Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
